Ireland's most popular source of accurate and reliable medicines information

Search 2626 medicines for SPCs, PILs and Educational Materials

COVID-19 Vaccine Information

Learn More
Eli Lilly and Company (Ireland) Limited
Sanofi Pasteur
Ferring Ireland Limited
LEO Pharma
Reckitt Benckiser Ireland Limited
Ipsen Pharmaceuticals Limited
Servier Laboratories Ireland Ltd
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
AstraZeneca Pharmaceuticals (Ireland) DAC
Dermal Laboratories Limited
Amgen Ireland Ltd
Mundipharma Pharmaceuticals Limited  - Formerly Napp Laboratories
Lundbeck (Ireland) Limited
Novartis Ireland Limited
Pfizer Healthcare Ireland
Orion Pharma (Ireland) Ltd
Allergan Ltd
Gerard Laboratories
Stiefel Ireland
Boehringer Ingelheim Limited

About Medicines.ie

Medicines.ie contains accurate, up to date, regulator approved information on medicines available in Ireland. The site is designed to be a comprehensive and easily searchable source of medicines information in Ireland.

It is widely regarded as an invaluable reference source by healthcare professionals, the National Medicines Information Center and the Department of Health.

The information for each product comes in the form of a Summary of Product Characteristics (SPC or SmPC) and Patient Information Leaflet (PIL) or Package Leaflet (PL), where relevant. These documents are approved by the medicines’ regulator (HPRA or EMA) as part of the process of authorising a medicine for sale or supply in Ireland.

Medicines.ie is continuously updated by pharmaceutical companies when new medicines are launched or the information for an existing medicine changes.

Using Medicines.ie

For information on types of documents on www.medicines.ie, please see below.

  • SPC

    Summary of Product Characteristics

    Summaries of product characteristics form the basis of information for healthcare professionals on how to use the medicine safely and effectively. Abbreviated as SPC.

  • PIL

    Patient Information Leaflet

    A PIL is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the SPC.

  • EDM

    Educational Materials

    EDMs are additional risk minimisation measures that are intended to promote the safe and effective use of the medicine. Educational materials focus on one or more specific safety concerns related to use of the medicine.

  • XPIL

    XPIL

    Some pharmaceutical companies have chosen to display PIL in a HTML text only “Print View” version, called an XPIL, as well as in PDF format. The XPIL is designed for people with sight challenges.